본문 바로가기
KERD
논문KCI 등재

Immunoenhancing Effects of Euglena gracilis on a Cyclophosphamide-Induced Immunosuppressive Mouse Model

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류생물학

초록

In this study, the effects of the immune stimulator Euglena gracilis (Euglena) in cyclophosphamide (CCP)-induced immunocompromised mice were assessed. The key component β-1,3-glucan (paramylon) constitutes 50% of E. gracilis. Mice were orally administered Euglena powder (250 and 500 mg/kg body weight (B.W.)) or β-glucan powder (250 mg/kg B.W.) for 19 days. In a preliminary immunology experiment, ICR mice were intraperitoneally injected with 80 mg of CCP/kg B.W. during the final 3 consecutive days. In the main experiment, BALB/c mice were treated with CCP for the final 5 days. To evaluate the enhancing effects of Euglena on the immune system, mouse B.W., the spleen index, natural killer (NK) cell activity and mRNA expression in splenocytes lungs and livers were determined. To detect cytokine and receptor expression, splenocytes were treated with 5 μg/ml concanavalin A or 1 μg/ml lipopolysaccharide. The B.W. and spleen index were significantly increased and NK cell activity was slightly enhanced in all the experimental groups compared to the CCP-only group. In splenocytes, the gene expression levels of tumor necrosis factor-α, interferon-γ, interleukin (IL)-10, IL-6, and IL-12 receptor were increased in the E. gracilis and β-glucan groups compared to the CCP-only group, but there was no significant difference. Treatment with 500mg of Euglena/kg B.W. significantly upregulated dectin-1 mRNA expression in the lung and liver compared to the CCP-only group. These results suggest that Euglena may enhance the immune system by strengthening innate immunity through immunosuppression.

Abstract

In this study, the effects of the immune stimulator Euglena gracilis (Euglena) in cyclophosphamide (CCP)-induced immunocompromised mice were assessed. The key component β-1,3-glucan (paramylon) constitutes 50% of E. gracilis. Mice were orally administered Euglena powder (250 and 500 mg/kg body weight (B.W.)) or β-glucan powder (250 mg/kg B.W.) for 19 days. In a preliminary immunology experiment, ICR mice were intraperitoneally injected with 80 mg of CCP/kg B.W. during the final 3 consecutive days. In the main experiment, BALB/c mice were treated with CCP for the final 5 days. To evaluate the enhancing effects of Euglena on the immune system, mouse B.W., the spleen index, natural killer (NK) cell activity and mRNA expression in splenocytes lungs and livers were determined. To detect cytokine and receptor expression, splenocytes were treated with 5 μg/ml concanavalin A or 1 μg/ml lipopolysaccharide. The B.W. and spleen index were significantly increased and NK cell activity was slightly enhanced in all the experimental groups compared to the CCP-only group. In splenocytes, the gene expression levels of tumor necrosis factor-α, interferon-γ, interleukin (IL)-10, IL-6, and IL-12 receptor were increased in the E. gracilis and β-glucan groups compared to the CCP-only group, but there was no significant difference. Treatment with 500mg of Euglena/kg B.W. significantly upregulated dectin-1 mRNA expression in the lung and liver compared to the CCP-only group. These results suggest that Euglena may enhance the immune system by strengthening innate immunity through immunosuppression.

참고문헌 (86)

  1. Shin JS, "Immunostimulatory effects of cordycepin-enriched WIB-801CE from Cordyceps militaris in splenocytes and cyclophosphamide-induced immunosuppressed mice", Phytother. Res, 32, pp.132~139 (2018)
  2. Pearce EJ, "Dendritic cell metabolism", Nat. Rev. Immunol, 15, pp.18~29 (2015)
  3. Hile G, "Recent genetic advances in innate immunity of psoriatic arthritis", Clin. Immunol, 214, pp.108405~ (2020)
  4. Kurowska-Stolarska M, "Synovial tissue macrophages : friend or foe? RMD Open", 3, pp.e000527~ (2017)
  5. O'Leary JG, "T cell-and B cell-independent adaptive immunity mediated by natural killer cells", Nat. Immunol, 7, pp.507~516 (2006)
  6. Ding J, "β-Glucan induces autophagy in dendritic cells and influences T-cell differentiation", Med. Microbiol. Immunol, 208, pp.39~48 (2019)
  7. Shokryazdan P, "Effects of prebiotics on immune system and cytokine expression", Med. Microbiol. Immunol, 206, pp.1~9 (2017)
  8. Phillips FC, "Particulate and solubilized beta-glucan and non-beta-glucan fractions of Euglena gracilis induce pro-and anti-inflammatory innate immune cell responses and exhibit antioxidant properties", J. Inflamm. Res, 12, pp.49~64 (2019)
  9. Buetow DE, "Polypeptide composition of thylakoid membranes: two-dimensional gel analysis during development of Euglena chloroplasts", Prog. Clin. Biol. Res, 102, pp.139~148 (1982)[DOI]
  10. Nakashima A, "Oral administration of Euglena gracilis Z and its carbohydrate storage substance provides survival protection against influenza virus infection in mice", Biochem. Biophys. Res. Commun, 494, pp.379~383 (2017)
  11. Nakashima A, "Anti-fibrotic activity of Euglena gracilis and paramylon in a mouse model of non-alcoholic steatohepatitis", Food Sci. Nutr, 7, pp.139~147 (2019)
  12. Aemiro A, "Effects of Euglena(Euglena gracilis)supplemented to diet(forage : concentrate ratios of 60 : 40)on the basic ruminal fermentation and methane emissions in in vitro condition", Anim. Feed Sci. Technol, 212, pp.129~135 (2016)
  13. Matsumoto T, "Comparison of Nutrients in Euglena with those in other representative food sources", Eco-Eng, 21, pp.81~86 (2009)
  14. Yasuda K, "Euglena Gracilis and beta-Glucan Paramylon Induce Ca(2+)signaling in intestinal tract epithelial, immune, and neural cells", Nutrients, 12, pp.2293~ (2020)
  15. Russo R, "Euglena gracilis paramylon activates human lymphocytes by upregulating pro-inflammatory factors", Food Sci. Nutr, 5, pp.205~214 (2017)
  16. Shimada R, "Oral administration of green algae, Euglena gracilis, inhibits hyperglycemia in OLETF rats, a model of spontaneous type 2 diabetes", Food Funct, 7, pp.4655~4659 (2016)
  17. Sakanoi Y, "Simultaneous intake of Euglena Gracilis and vegetables synergistically exerts an anti-inflammatory effect and attenuates visceral fat accumulation by affecting gut microbiota in mice", Nutrients, 10, pp.1417~ (2018)
  18. Ran Okouchi, "Simultaneous Intake of Euglena gracilis and Vegetables Exerts Synergistic Anti-Obesity and Anti-Inflammatory Effects by Modulating the Gut Microbiota in Diet-Induced Obese Mice", Nutrients, 11(1), pp.204~ (2019), MDPI AG[DOI]
  19. Aoe S, "Effects of paramylon extracted from Euglena gracilis EOD-1 on parameters related to metabolic syndrome in diet-induced obese mice", Nutrients, 11, pp.1674~ (2019)
  20. Ishibashi KI, "Effects of Euglena gracilis EOD-1 ingestion on salivary IgA reactivity and health-related quality of life in humans", Nutrients, 11, pp.1144~ (2019)
  21. Liu X, "Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb", c mice, 2019, pp.72, 98~111
  22. Barnes H, "Cyclophosphamide for connective tissue disease-associated interstitial lung disease", Cochrane Database Syst. Rev, 1, pp.CD010908~ (2018)
  23. 김경진, "Immune-Enhancing Effects of Lactobacillus plantarum 200655 Isolated from Korean Kimchi in a Cyclophosphamide-Induced Immunocompromised Mouse Model", Journal of Microbiology and Biotechnology, 31(5), pp.726~732 (2021), 한국미생물·생명공학회[DOI]
  24. Ahlmann M, "The effect of cyclophosphamide on the immune system : implications for clinical cancer therapy", Cancer Chemother. Pharmacol, 78, pp.661~671 (2016)
  25. Müller US, "Suppressive effects in mesenchyme and immunosuppressive effects of cytostatica", Int. J. Clin. Pharmacol, 7, pp.228~233 (1973)
  26. Muller US, "Animal experiments on the anti-inflammatory and immunosuppressive effect of cytostatic agents", Arzneimittelforschung, 23, pp.487~491 (1973)
  27. Li W, "Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation", Int. J. Biol. Macromol, 145, pp.985~997 (2020)
  28. Mao GH, "Anti-tumor and immunomodulatory activity of selenium(Se)-polysaccharide from Se-enriched Grifola frondosa", Int. J. Biol. Macromol, 82, pp.607~613 (2016)
  29. Jiahong Han, "Studies of the effects and mechanisms of ginsenoside Re and Rk3 on myelosuppression induced by cyclophosphamide", Journal of Ginseng Research, 43(4), pp.618~624 (2019), 고려인삼학회[DOI]
  30. Lei M, "Study of the radio-protective effect of cuttlefish ink on hemopoietic injury", Asia Pac. J. Clin. Nutr, 16(1), pp.239~243 (2007)
  31. Monmai C, "Immune-enhancing effects of anionic macromolecules extracted from Codium fragile on cyclophosphamide-treated mice", PLoS One, 14, pp.e0211570~ (2019)
  32. Lori A, "The spleen : a hub connecting nervous and immune systems in cardiovascular and metabolic diseases", Int. J. Mol. Sci, 18, pp.1216~ (2017)
  33. Sarangi I, "Anti-tumor and immunomodulating effects of Pleurotus ostreatus mycelia-derived proteoglycans", Int. Immunopharmacol, 6, pp.1287~1297 (2006)
  34. Wahyuningsih SPA, "Crude polysaccharides from okra pods(Abelmoschus esculentus)grown in Indonesia enhance the immune response due to bacterial infection", Adv. Pharmacol. Sci, 2018, pp.8505383~ (2018)
  35. Zhang J, "Natural killer cells and current applications of chimeric antigen receptor-modified NK-92 cells in tumor immunotherapy", Int. J. Mol. Sci, 20, pp.317~ (2019)
  36. Campbell KS, "Natural killer cell biology : an update and future directions", J. Allergy Clin. Immunol, 132, pp.536~544 (2013)
  37. Cerwenka A, "Natural killer cell memory in infection, inflammation and cancer", Nat. Rev. Immunol, 16, pp.112~123 (2016)
  38. Hammer Q, "Natural killer cell specificity for viral infections", Nat. Immunol, 19, pp.800~808 (2018)
  39. Pech MF, "Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance", Elife, 8, pp.e47362~ (2019)
  40. Talmadge JE, "Role of NK cells in tumour growth and metastasis in beige mice", Nature, 284, pp.622~624 (1980)
  41. Fehniger TA, "Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12 : implications for the innate immune response", J. Immunol, 162, pp.4511~4520 (1999)
  42. Ferlazzo G, "NK cell compartments and their activation by dendritic cells", J. Immunol, 172, pp.1333~1339 (2004)
  43. Zitvogel L, "Dendritic cell-NK cell cross-talk : regulation and physiopathology", Curr. Top. Microbiol. Immunol, 298, pp.157~174 (2006)
  44. Chijioke O, "Dendritic cell derived cytokines in human natural killer cell differentiation and activation", Front. Immunol, 4, pp.365~ (2013)
  45. Bald T, "The role of NK cell as central communicators in cancer immunity", Adv. Immunol, 147, pp.61~88 (2020)
  46. Paul S, "The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy", Front. Immunol, 8, pp.1124~ (2017)
  47. Capellino S, "Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine", Cell. Mol. Immunol, 17, pp.705~711 (2020)
  48. 이연주, "Agrobacterium sp.-derived β-1,3-glucan enhances natural killer cell activity in healthy adults: a randomized, double-blind, placebo-controlled, parallel-group study", Nutrition Research and Practice, 11(1), pp.43~50 (2017), 한국영양학회
  49. Kumar BV, "Human T Cell development, localization, and function throughout life", Immunity, 48, pp.202~213 (2018)
  50. Jansen JM, "Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination", J. Clin. Virol, 119, pp.44~52 (2019)
  51. Fischer U, "Cell fate decisions : The role of transcription factors in early B-cell development and leukemia", Blood Cancer Discov, 1, pp.224~233 (2020)
  52. Kondo M, "Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors", Immunol. Rev, 238, pp.37~46 (2010)
  53. Pelanda R, "Central B-cell tolerance : where selection begins", Cold Spring Harb Perspect. Biol, 4, pp.a007146~ (2012)
  54. Akrami M, "Circulation of gut-preactivated naive CD8(+)T cells enhances antitumor immunity in B cell-defective mice", Proc. Natl. Acad. Sci. USA, 117, pp.23674~23683 (2020)
  55. Bastian D, "The IL-12 Cytokine and receptor family in graft-vs.-host disease", Front. Immunol, 10, pp.988~ (2019)
  56. Presky DH, "A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits", Proc. Natl. Acad. Sci. USA, 93, pp.14002~14007 (1996)
  57. Wu C, "IL-12 receptor beta 2(IL-12R beta 2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites", J. Immunol, 165, pp.6221~6228 (2000)
  58. Chyuan IT, "New insights into the IL-12 and IL-23 : from a molecular basis to clinical application in immune-mediated inflammation and cancers", Biochem. Pharmacol, 175, pp.113928~ (2020)
  59. Vignali DA, "IL-12 family cytokines : immunological playmakers", Nat. Immunol, 13, pp.722~728 (2012)
  60. Kak G, "Interferon-gamma(IFN-gamma) : exploring its implications in infectious diseases", Biomol. Concepts, 9, pp.64~79 (2018)
  61. Raphael I, "T cell subsets and their signature cytokines in autoimmune and inflammatory diseases", Cytokine, 74, pp.5~17 (2015)
  62. Park H-E, "Immune enhancing effects of Weissella cibaria JW15 on BALB", c mice immunosuppressed by cyclophosphamide, 2018, pp.49, 518~525
  63. Guo Q, "Immune activation of murine RAW264.7 macrophages by sonicated and alkalized paramylon from Euglena gracilis", BMC Microbiol, 20, pp.171~ (2020)
  64. Bedke T, "Title : IL-10-producing T cells and their dual functions", Semin. Immunol, 44, pp.101335~ (2019)
  65. Foulds KE, "IL-10 is required for optimal CD8 T cell memory following Listeria monocytogenes infection", J. Immunol, 177, pp.2565~2574 (2006)
  66. Mumm JB, "IL-10 elicits IFNgamma-dependent tumor immune surveillance", Cancer Cell, 20, pp.781~796 (2011)
  67. Fujii S, "Interleukin-10 promotes the maintenance of antitumor CD8(+)T-cell effector function in situ", Blood, 98, pp.2143~2151 (2001)
  68. Levy Y, "Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein", J. Clin. Invest, 93, pp.424~428 (1994)
  69. Xin G, "Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection", Nat. Commun, 9, pp.5037~ (2018)
  70. Brown GD, "A new receptor for β-glucans", Nature, 413, pp.36~37 (2001)
  71. Kalia N, "The role of dectin-1 in health and disease", Immunobiology, 226, pp.152071~ (2021)
  72. Huysamen C, "The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptors", FEMS Microbiol. Lett, 290, pp.121~128 (2009)
  73. Taylor PR, "The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte", macrophage and neutrophil lineages, 2002, pp.169, 3876~3882
  74. Willment JA, "The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells", Eur. J. Immunol, 35, pp.1539~1547 (2005)
  75. Brown GD, "Dectin-1 is a major beta-glucan receptor on macrophages", J. Exp. Med, 196, pp.407~412 (2002)
  76. Gantner BN, "Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2", J. Exp. Med, 197, pp.1107~1117 (2003)
  77. Rogers NC, "Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins", Immunity, 22, pp.507~517 (2005)
  78. De Marco Castro E, "beta-1, 3", 1, 6-Glucans and immunity : state of the art and future directions, 2021, pp.65, e1901071~
  79. Goodridge HS, "Beta-glucan recognition by the innate immune system", Immunol. Rev, 230, pp.38~50 (2009)
  80. Inoue M, "β-glucan suppresses cell death of ASC deficient macrophages invaded by periodontopathic bacteria through the caspase-11 pathway", FEMS Microbiol. Lett, 366, pp.093~ (2019)
  81. Li X, "betaglucan, a dectin1 ligand, promotes macrophage M1 polarization via NFkappaB", autophagy pathway, 2019, pp.54, 271~282
  82. Brown GD, "Immune recognition", A new receptor for beta-glucans. Nature, 413, pp.36~37 (2001)
  83. Herre J, "Dectin-1 and its role in the recognition of beta-glucans by macrophages", Mol. Immunol, 40, pp.869~876 (2004)
  84. Calvayrac R, "Paramylon synthesis by Euglena gracilis photoheterotrophically grown under low O2 pressure : Description of a mitochloroplast complex", Planta, 153, pp.6~13 (1981)
  85. Monfils AK, "Characterization of paramylon morphological diversity in photosynthetic euglenoids(Euglenales, Euglenophyta)", Phycologia, 50, pp.156~169 (2011)
  86. Barsanti L, "Paramylon, a potent immunomodulator from WZSL mutant of Euglena gracilis", Molecules, 24, pp.3114~ (2019)

관련 논문AI추천

Evaluation of the Effects of Euglena gracilis on Enhancing Immune Responses in RAW264.7 Cells and a Cyclophosphamide- Induced Mouse ModelHwang Ji Eun, Jeon Jin-Young, Jo Kyeong Ah, Kim Ji Yeon, Kim Kyeong Jin, Park Soo-yeon한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2023 · 제33권 제4호Unveiling Immunomodulatory Effects of Euglena gracilis in Immunosuppressed Mice: Transcriptome and Pathway AnalysisJo Kyeong Ah, Jo Seon Ha, Kim Ji Yeon, Park Soo-yeon한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2024 · 제34권 제4호Immune-Enhancing Effects of Crude Polysaccharides from Korean Ginseng Berries on Spleens of Mice with Cyclophosphamide-Induced Immunosuppression남주현, 박우정, Choi JeongUn, Jang A-yeong, Monmai Chaiwat, Rod-in Weerawan, You SangGuan한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2022 · 제32권 제2호Immune-boosting Effects of Chrysanthemum zawadskii Herbich var. latilobum Kitamura Extract on Cyclophosphamide-induced Immunosuppressed Sprague-Dawley Animal Model김재곤, 박영미, 신동엽, 이병열, 이학용한국약용작물학회 · 한국약용작물학회지2023 · 제31권 제2호Immune-enhancing effect of hydrolyzed and fermented Platycodon grandiflorum extract in cyclophosphamide-induced immunosuppressed BALB/c mice이현숙, Jung Jae In, Kim Eun Ji, Kim So Mi, Lim Jihoon, Woo Moonjea한국영양학회 · Nutrition Research and Practice2023 · 제17권 제2호Korean Ginseng Berry Polysaccharide Enhances Immunomodulation Activities of Peritoneal Macrophages in Mice with Cyclophosphamide-Induced Immunosuppression박우정, Choi JeongUn, Jang A-yeong, Monmai Chaiwat, Nam Ju Hyun, Rod-in Weerawan, You SangGuan한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2023 · 제33권 제6호

이 간행물의 다른 논문 (14건)